These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30575598)

  • 1. Patient perspectives in gout: a review.
    Singh JA
    Curr Opin Rheumatol; 2019 Mar; 31(2):159-166. PubMed ID: 30575598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rate of adherence to urate-lowering therapy and associated factors in Chinese gout patients: a cross-sectional study.
    Yin R; Cao H; Fu T; Zhang Q; Zhang L; Li L; Gu Z
    Rheumatol Int; 2017 Jul; 37(7):1187-1194. PubMed ID: 28551724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of nurse intervention on engagement with urate-lowering drugs: A qualitative study of participants in a RCT of nurse led care.
    Latif ZP; Nakafero G; Jenkins W; Doherty M; Abhishek A
    Joint Bone Spine; 2019 May; 86(3):357-362. PubMed ID: 30394337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout.
    Richardson JC; Liddle J; Mallen CD; Roddy E; Hider S; Prinjha S; Ziebland S
    BMC Musculoskelet Disord; 2016 Jun; 17():249. PubMed ID: 27267878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient Perspectives and Preferences Regarding Gout and Gout Management: Impact on Adherence.
    Chung MK; Kim SS; Cheon YH; Hong SJ; Choi HJ; Seo MR; Hwang J; Ahn JK; Lee SH; Min HK; Cha HS; Lee SS; Lee J; Moon KW; Lee CK; Kim HO; Suh YS; Shim SC; Kang SW; Kim J; Choi ST; Song JS; Lee J;
    J Korean Med Sci; 2021 Aug; 36(32):e208. PubMed ID: 34402226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming adherence issues and other barriers to optimal care in gout.
    Nasser-Ghodsi N; Harrold LR
    Curr Opin Rheumatol; 2015 Mar; 27(2):134-8. PubMed ID: 25633242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to urate-lowering therapy.
    Day RO
    South Med J; 2009 Jan; 102(1):114-5. PubMed ID: 19077754
    [No Abstract]   [Full Text] [Related]  

  • 8. Achieving serum urate targets in gout: an audit in a gout-oriented rheumatology practice.
    Corbett EJM; Pentony P; McGill NW
    Int J Rheum Dis; 2017 Jul; 20(7):894-897. PubMed ID: 28205336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Response or Non-response to Urate-Lowering Therapy in Patients with Gout.
    Graham GG; Stocker SL; Kannangara DRW; Day RO
    Curr Rheumatol Rep; 2018 Jun; 20(8):47. PubMed ID: 29931553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health literacy in patients dealing with gout: a qualitative study.
    van Onna M; Hinsenveld E; de Vries H; Boonen A
    Clin Rheumatol; 2015 Sep; 34(9):1599-603. PubMed ID: 25501463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The patient's experience of gout: new insights to optimize management.
    Dalbeth N; Lindsay K
    Curr Rheumatol Rep; 2012 Apr; 14(2):173-8. PubMed ID: 22198831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients.
    Janssen CA; Jansen TLTA; Oude Voshaar MAH; Vonkeman HE; van de Laar MAFJ
    Rheumatol Int; 2017 Sep; 37(9):1435-1440. PubMed ID: 28748426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence and persistence to urate-lowering therapies in the Irish setting.
    McGowan B; Bennett K; Silke C; Whelan B
    Clin Rheumatol; 2016 Mar; 35(3):715-21. PubMed ID: 25409858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient and clinical characteristics associated with gout flares in an integrated healthcare system.
    Rashid N; Levy GD; Wu YL; Zheng C; Koblick R; Cheetham TC
    Rheumatol Int; 2015 Nov; 35(11):1799-807. PubMed ID: 25991397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Casebook consults: improving outcomes in gout (multimedia activity).
    Doghramji PP; Mandell BF; Pope RS
    Am J Med; 2012 Aug; 125(8):S1. PubMed ID: 22840678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term persistence and adherence on urate-lowering treatment can be maintained in primary care-5-year follow-up of a proof-of-concept study.
    Abhishek A; Jenkins W; La-Crette J; Fernandes G; Doherty M
    Rheumatology (Oxford); 2017 Apr; 56(4):529-533. PubMed ID: 28082620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A qualitative study to explore health professionals' experience of treating gout: understanding perceived barriers to effective gout management.
    Humphrey C; Hulme R; Dalbeth N; Gow P; Arroll B; Lindsay K
    J Prim Health Care; 2016 Jun; 8(2):149-56. PubMed ID: 27477557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of adherence to urate-lowering therapy among patients with gout: a systematic review and meta-analysis.
    Yin R; Li L; Zhang G; Cui Y; Zhang L; Zhang Q; Fu T; Cao H; Li L; Gu Z
    BMJ Open; 2018 Apr; 8(4):e017542. PubMed ID: 29643150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why better treatment of gout is needed.
    So AK
    Clin Exp Rheumatol; 2016; 34(4 Suppl 98):63-5. PubMed ID: 27586807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Is the Evidence for Treat-to-Target Serum Urate in Gout?
    Bursill D; Dalbeth N
    Curr Rheumatol Rep; 2018 Mar; 20(3):11. PubMed ID: 29516287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.